Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.50 USD
Change Today -0.01 / -0.40%
Volume 7.8K
As of 1:58 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Wayne T. Hockmeyer Ph.D.

Chairman of the Board, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee,GenVec, Inc.
AgeTotal Calculated CompensationThis person is connected to 37 board members in 5 different organizations across 15 different industries.

See Board Relationships


Dr. Wayne T. Hockmeyer, Ph.D. served as the President at MedImmune Ventures Inc., a wholly-owned subsidiary of MedImmune Inc. from 2002 to June 1, 2007. Dr. Hockmeyer founded MedImmune, Inc. in April 1988 and served as its President and Chief Executive Officer from April 1988 to October 2000. From 1986 to 1988, he served as a Vice President of Research and Development at Praxis Biologics Inc. He was also employed at QIAGEN Gaithersburg, Inc. He served as the Chairman ...

Read Full Background

Corporate Headquarters*

910 Clopper Road
Gaithersburg, Maryland 20878

United States

Phone: 240-632-0740
Fax: 240-632-0735

Board Members Memberships*

Non-Executive Chairman, Chairman of Corporate Governance Committee, Member of Compensation Committee and Member of Quality and Compliance Committee
Chairman of the Board, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Chairman, Member of Audit Committee, Member of Nominating Committee and Member of Corporate Governance Committee


ScD 2002
Purdue University
BS 1966
Purdue University
PhD 1972
University of Florida

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options25,500
Unexercisable Options22,500
Total Number of Options48,000

Total Compensation*

Total Annual Cash Compensation$40,000
Total Calculated Compensation$78,033
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNVC:US $2.50 USD -0.01


Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
Kalevi Reijonen M.D.Chief Executive Officer and President
FIT Biotech Oy
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENVEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at